Skip to main content

Table 2 Infusion-related signs/symptoms reported by patients at the infusion site during the attacks

From: Safety, effectiveness, and impact on quality of life of self-administration with plasma-derived nanofiltered C1 inhibitor (Berinert®) in patients with hereditary angioedema: the SABHA study

Infusion-related signs/symptoms at the infusion site

Absent

Mild

Moderate

Severe

Swelling

123 (66%)

16 (9%)

15 (8%)

33 (18%)

Reddening

122 (65%)

8 (4%)

57 (30%)

0 (0%)

Burning

120 (64%)

47 (25%)

20 (11%)

0 (0%)

Itch

183 (98%)

2 (1%)

2 (1%)

0 (0%)

Feeling of warmth

185 (99%)

2 (1%)

0 (0%)

0 (0%)

Pain

111 (59%)

5 (3%)

56 (30%)

15 (8%)